Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD

PURPOSE: To determine the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI 36/9.6, 36/7.2, 18/9.6, 9/9.6 µg) using innovative co-suspension delivery technology, compared with glycopyrrolate (GP) MDI 36 µg and formoterol fumarate (FF) MDI 9.6 µg, in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Reisner, Colin, Pearle, James, Kerwin, Edward M, Rose, Earl St, Darken, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016010/
https://www.ncbi.nlm.nih.gov/pubmed/29950826
http://dx.doi.org/10.2147/COPD.S166455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016010/
https://www.ncbi.nlm.nih.gov/pubmed/29950826
http://dx.doi.org/10.2147/COPD.S166455

Ejemplares similares